CN105770758A - Drug for treating stroke paralysis - Google Patents

Drug for treating stroke paralysis Download PDF

Info

Publication number
CN105770758A
CN105770758A CN201610259987.8A CN201610259987A CN105770758A CN 105770758 A CN105770758 A CN 105770758A CN 201610259987 A CN201610259987 A CN 201610259987A CN 105770758 A CN105770758 A CN 105770758A
Authority
CN
China
Prior art keywords
parts
radix
rhizoma
grams
herba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610259987.8A
Other languages
Chinese (zh)
Inventor
涂已文
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610259987.8A priority Critical patent/CN105770758A/en
Publication of CN105770758A publication Critical patent/CN105770758A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/79—Schisandraceae (Schisandra family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A61K35/583—Snakes; Lizards, e.g. chameleons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/237—Notopterygium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/264—Aristolochia (Dutchman's pipe)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296—Epimedium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/344—Codonopsis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/51—Gentianaceae (Gentian family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/538—Schizonepeta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/64—Orobanchaceae (Broom-rape family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714—Aconitum (monkshood)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/716—Clematis (leather flower)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718—Coptis (goldthread)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/732—Chaenomeles, e.g. flowering quince
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/882—Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8884—Arisaema, e.g. Jack in the pulpit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/89—Cyperaceae (Sedge family)
    • A61K36/8905—Cyperus (flatsedge)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A61K36/8988—Gastrodia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a drug for treating stroke paralysis, which comprises medical compositions respectively used at three phases. Herbs at the first phase comprise schisandra chinensis baill root, helixanthera sampsoni, sargentgloryvine stem, turmeric, erycibe obtusifolia benth, lycopodium clavatum, cassia twig, radix achyranthis bidentatae, codonopsis pilosula, frankincense, myrrh, notopterygium root, radix angelicae pubescentis, large-leaved gentian, rhizoma cyperi, radix linderae, prepared rhizome of rehmannia, eucommia ulmoides and fructus aurantii; herbs at the second phase comprise arisaema consanguineum schott, erycibe obtusifolia benth, lycopodium clavatum, radix achyranthis bidentatae, rhizoma cyperi, ligusticum wallichii, eucommia ulmoides, angelica sinensis, coptis chinensis, radix clematidis, herba epimedii, tiger bone, rhizoma curculiginis, prepared rhizome of rehmannia, cinnamomum cassia, large-leaved gentian, sargentgloryvine stem, schisandra chinensis baill root and pawpaw; herbs at the third phase comprise arisaema consanguineum schott, long-noded pit viper, radix aconite, colla cornus cervi, radix ginseng, angelica sinensis, ligusticum wallichii, cortex cinnamomi, rhizoma gastrodiae, herba epimedii, semen cuscutae, uncaria rhynchophylla, asarum, schizonepeta, calamus, radix rehmanniae, prepared rhizome of rehmannia, cistanche, cortex acanthopanacis and rhizoma curculiginis. The drug for treating the stroke paralysis, provided by the invention, is reasonable in compatibility, complementary and synergistic, and dialectical in treatment and has the advantages of being quick in effect taking, good in curative effect and free from toxic and side effects.

Description

A kind of medicine treating paralysis due to windstroke
Technical field
The present invention relates in the field of Chinese medicines, specifically a kind of medicine treating paralysis due to windstroke.
Background technology
Apoplexy is one group of disease being main clinical manifestation with cerebral ischemic and heamorrhagic lesions symptom, also known as apoplexy or cerebrovas-cularaccident, has high case fatality rate and disability rate.Its sequela generally has numbness, facial hemiparalysis, paralysis, paralysis, aphasia and mistake knowledge etc..Paralysis due to windstroke is generally divided into central paralysis and lower motor neuron paralysis, and central paralysis main manifestations is hypermyotonia, and tendon hyperreflexia pathologic reflex occurs, in spastic paralysis.Lower motor neuron paralysis shows as muscular tension reduction, hyporeflexia or disappearance, accompanies amyotrophy, but without pathologic reflex.The annual paralytic caused by apoplexy is increasing year by year, these patients disability in various degree and self care ability, brings white elephant to family and society.And the treatment of paralysis is not had good medicine, at present still to put prevention first.
Summary of the invention
For above-mentioned technical problem, the present invention provides a kind of medicine treating paralysis due to windstroke, includes the pharmaceutical composition that 3 stages used respectively altogether, wherein:
First stage pharmaceutical composition includes the component of following weight portion: root of Fructus Schisandrae Chinensis 5～15 parts, oil tea parasitism 5～15 parts, big Caulis Sargentodoxae 5～15 parts, 5～12 parts of Rhizoma Curcumae Longae, Caulis Erycibes 5～10 parts, Herba Lycopodii 5～15 parts, Ramulus Cinnamomi 5～12 parts, Radix Achyranthis Bidentatae 5～15 parts, Radix Codonopsis 5～15 parts, Olibanum 5～12 parts, Myrrha 5～12 parts, Rhizoma Et Radix Notopterygii 5～12 parts, Radix Angelicae Pubescentis 5～12 parts, Radix Gentianae Macrophyllae 5～12 parts, Rhizoma Cyperi 5～15 parts, the Radix Linderae 5～15 parts, 5～15 parts of Radix Rehmanniae Preparata, the Cortex Eucommiae 5～10 parts, Fructus Aurantii 5～15 parts；
Second stage pharmaceutical composition includes the component of following weight portion: Rhizoma Arisaematis 5～10 parts, Caulis Erycibes 5～10 parts, Herba Lycopodii 5～15 parts, Radix Achyranthis Bidentatae 5～15 parts, Rhizoma Cyperi 5～15 parts, Rhizoma Chuanxiong 5～15 parts, the Cortex Eucommiae 5～10 parts, Radix Angelicae Sinensis 5～15 parts, Rhizoma Coptidis 5～10 parts, Radix Clematidis 5～15 parts, Herba Epimedii 5～15 parts, Os Tigris 5～15 parts, Rhizoma Curculiginis 5～10 parts, 5～15 parts of Radix Rehmanniae Preparata, Cortex Cinnamomi 5～10 parts, Radix Gentianae Macrophyllae 5～15 parts, big Caulis Sargentodoxae 5～15 parts, root of Fructus Schisandrae Chinensis 5～15 parts, Fructus Chaenomelis 5～15 parts；
Phase III pharmaceutical composition includes the component of following weight portion: Rhizoma Arisaematis 5～10 parts, Agkistrodon 5～15 parts, Radix Aconiti 1～10 part, Colla cornus cervi 1～10 part, Radix Ginseng 5～15 parts, Radix Angelicae Sinensis 5～15 parts, Rhizoma Chuanxiong 5～15 parts, Cortex Cinnamomi 1～5 part, 5～15 parts of Rhizoma Gastrodiae, Herba Epimedii 5～15 parts, Semen Cuscutae 5～15 parts, Ramulus Uncariae Cum Uncis 5～15 parts, Herba Asari 1～10 part, Herba Schizonepetae 5～15 parts, Rhizoma Acori Graminei 5～15 parts, 5～15 parts of the Radix Rehmanniae, 5～15 parts of Radix Rehmanniae Preparata, Herba Cistanches 5～15 parts, Cortex Acanthopancis 5～15 parts, Rhizoma Curculiginis 5～10 parts.
Further, described first stage pharmaceutical composition includes the component of following weight portion: root of Fructus Schisandrae Chinensis 8～12 parts, oil tea parasitism 8～12 parts, big Caulis Sargentodoxae 8～12 parts, 8～11 parts of Rhizoma Curcumae Longae, Caulis Erycibes 6～9 parts, Herba Lycopodii 8～12 parts, Ramulus Cinnamomi 8～11 parts, Radix Achyranthis Bidentatae 8～12 parts, Radix Codonopsis 8～12 parts, Olibanum 8～11 parts, Myrrha 8～11 parts, Rhizoma Et Radix Notopterygii 8～11 parts, Radix Angelicae Pubescentis 8～11 parts, Radix Gentianae Macrophyllae 8～11 parts, Rhizoma Cyperi 8～12 parts, the Radix Linderae 8～12 parts, 8～12 parts of Radix Rehmanniae Preparata, the Cortex Eucommiae 6～9 parts, Fructus Aurantii 8～12 parts.
Specifically, described first stage pharmaceutical composition includes the component of following weight portion: root of Fructus Schisandrae Chinensis 10 parts, parasitic 10 parts of oil tea, big Caulis Sargentodoxae 10 parts, 10 parts of Rhizoma Curcumae Longae, Caulis Erycibes 8 parts, Herba Lycopodii 10 parts, Ramulus Cinnamomi 10 parts, Radix Achyranthis Bidentatae 10 parts, Radix Codonopsis 10 parts, Olibanum 10 parts, Myrrha 10 parts, Rhizoma Et Radix Notopterygii 10 parts, Radix Angelicae Pubescentis 10 parts, Radix Gentianae Macrophyllae 10 parts, Rhizoma Cyperi 10 parts, the Radix Linderae 10 parts, 10 parts of Radix Rehmanniae Preparata, the Cortex Eucommiae 8 parts, Fructus Aurantii 10 parts.
Further, described second stage pharmaceutical composition includes the component of following weight portion: Rhizoma Arisaematis 6～9 parts, Caulis Erycibes 6～9 parts, Herba Lycopodii 8～12 parts, Radix Achyranthis Bidentatae 8～12 parts, Rhizoma Cyperi 8～12 parts, Rhizoma Chuanxiong 8～12 parts, the Cortex Eucommiae 6～9 parts, Radix Angelicae Sinensis 8～12 parts, Rhizoma Coptidis 6～9 parts, Radix Clematidis 8～12 parts, Herba Epimedii 8～12 parts, Os Tigris 8～12 parts, Rhizoma Curculiginis 6～9 parts, 8～12 parts of Radix Rehmanniae Preparata, Cortex Cinnamomi 6～9 parts, Radix Gentianae Macrophyllae 8～12 parts, big Caulis Sargentodoxae 8～12 parts, root of Fructus Schisandrae Chinensis 8～12 parts, Fructus Chaenomelis 8～12 parts.
Further, described second stage pharmaceutical composition can also include Radix Et Rhizoma Rhei 3～5 parts.
Specifically, described second stage pharmaceutical composition includes the component of following weight portion: Rhizoma Arisaematis 8 parts, Caulis Erycibes 8 parts, Herba Lycopodii 10 parts, Radix Achyranthis Bidentatae 10 parts, Rhizoma Cyperi 10 parts, Rhizoma Chuanxiong 10 parts, the Cortex Eucommiae 8 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Coptidis 8 parts, Radix Clematidis 10 parts, Herba Epimedii 10 parts, Os Tigris 10 parts, Rhizoma Curculiginis 8 parts, 10 parts of Radix Rehmanniae Preparata, Cortex Cinnamomi 8 parts, Radix Gentianae Macrophyllae 10 parts, big Caulis Sargentodoxae 10 parts, root of Fructus Schisandrae Chinensis 10 parts, Fructus Chaenomelis 10 parts.
Further, described phase III pharmaceutical composition includes the component of following weight portion: Rhizoma Arisaematis 6～9 parts, Agkistrodon 8～12 parts, Radix Aconiti 3～8 parts, Colla cornus cervi 3～8 parts, Radix Ginseng 8～12 parts, Radix Angelicae Sinensis 8～12 parts, Rhizoma Chuanxiong 8～12 parts, Cortex Cinnamomi 2～4 parts, 8～12 parts of Rhizoma Gastrodiae, Herba Epimedii 8～12 parts, Semen Cuscutae 8～12 parts, Ramulus Uncariae Cum Uncis 8～12 parts, Herba Asari 3～8 parts, Herba Schizonepetae 8～12 parts, Rhizoma Acori Graminei 8～12 parts, 8～12 parts of the Radix Rehmanniae, 8～12 parts of Radix Rehmanniae Preparata, Herba Cistanches 8～12 parts, Cortex Acanthopancis 8～12 parts, Rhizoma Curculiginis 6～9 parts.
Specifically, described phase III pharmaceutical composition includes the component of following weight portion: Rhizoma Arisaematis 8 parts, Agkistrodon 10 parts, Radix Aconiti 5 parts, Colla cornus cervi 5 parts, Radix Ginseng 10 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Chuanxiong 10 parts, Cortex Cinnamomi 3 parts, 10 parts of Rhizoma Gastrodiae, Herba Epimedii 10 parts, Semen Cuscutae 10 parts, Ramulus Uncariae Cum Uncis 10 parts, Herba Asari 5 parts, Herba Schizonepetae 10 parts, Rhizoma Acori Graminei 10 parts, 10 parts of the Radix Rehmanniae, 10 parts of Radix Rehmanniae Preparata, Herba Cistanches 10 parts, Cortex Acanthopancis 10 parts, Rhizoma Curculiginis 8 parts.
The main component effect of the present invention is as follows:
Caulis Erycibes: acrid in the mouth, warm in nature.Return liver, spleen, stomach warp.Expelling wind and removing dampness, reducing swelling and alleviating pain.For rheumatic arthralgia, hemiplegia, tumbling and swelling.
Herba Lycopodii: bitter in the mouth, micro-pungent, warm in nature.Return liver,spleen,kidney warp.There is expelling wind and removing dampness, effect of relaxing muscles and tendons and activating QI and blood in the collateral.For joint aches, joint stuffiness.
Rhizoma Cyperi: hardship pungent, micro-, micro-sweet, flat.Return liver, spleen, tri-jiao channel.Dispersing the stagnated live-QI to relieve the stagnation of QI, regulating the flow of QI to ease the stomach, menstruction regulating and pain relieving.For stagnation of QI due to depression of the liver, distending pain in the chest and hypochondrium, hernia pain, distending pain of the breast, stagnation of QI in spleen and stomach, gastral cavity abdomen painful abdominal mass is vexed, distension pain, menoxenia, amenorrhea dysmenorrhea.
Radix Rehmanniae Preparata (formal name used at school: RehmanniaRadixPraeparata): for the Preparation process product of scrophulariaceae rehmannia glutinosa plant.Sweet, tepor.Return liver, kidney channel.Enrich blood yin nourishing, life essence-filling, marrow-benefitting.For blood deficiency and yellow complexion, cardiopalmus is levied swollen, menoxenia, metrostaxis, the hepatic and renal YIN deficiency, soreness of the waist and knees, osteopyrexia and fever etc..
Radix Gentianae Macrophyllae: acrid in the mouth, hardship, property is put down.Return stomach, liver, gallbladder meridian.There are wind-damp dispelling, clearing away damp-heat, stopping numbness pain, the effect of reducing the asthenic fever.For rheumatic arthralgia, apoplexy and hemiplegia, muscle arteries and veins contracture, joint is ached, jaundice due to damp-heat, osteopyrexia and fever, and infantile malnutrition generates heat.
Big Caulis Sargentodoxae: bitter；Flat；Nontoxic, return liver, large intestine channel；Removing toxicity for eliminating carbuncles；Promoting blood circulation and stopping pain；Expelling wind and removing dampness；Parasite killing.
Rhizoma Arisaematis: namely Rhizoma Arisaematis (ArisaemaRhizoma) is bitter, pungent, temperature；Poisonous.Return lung, liver, spleen channel.Mass dissipating and swelling eliminating.External treatment carbuncle, snake bite and insect sting are used in life.
Radix Angelicae Sinensis: sweet in the mouth, pungent, warm in nature.Return liver, the heart, spleen channel.Replenishing and activating blood, menstruction regulating and pain relieving, loosening bowel to relieve constipation.For blood deficiency and yellow complexion, dizziness cardiopalmus, menoxenia, amenorrhea dysmenorrhea, asthenia cold abdominalgia, rheumatic arthralgia, injury from falling down, ulcer sores, dryness of the intestine constipation.For amenorrhea dysmenorrhea, rheumatic arthralgia, injury from falling down.
Rhizoma Chuanxiong: acrid in the mouth, temperature.Enter liver, gallbladder meridian.Blood-activating and qi-promoting, method wind pain relieving.For obstruction of qi in the chest and cardialgia, breast side of body twinge, tumbling and swelling, menoxenia, headache, rheumatic arthralgia etc..
Cortex Cinnamomi: acrid in the mouth, sweet, extremely hot in nature.Return kidney, spleen, the heart, Liver Channel.There is benefit fire supporing yang, guiding fire to origin, dispersing cold for relieving pain, effect of promoting the flow of QI-blood by warming the meridian.For sexual impotence cold womb, chills and pain of the waist and kness, suffering from a deficiency of the kidney and breathe heavily, upward floating of YANG in deficiency condition, dizziness conjunctival congestion, trusted subordinate's cold type of pain, deficiency and coldness is vomited and diarrhoea, and colic of cold type is suffered from abdominal pain, dysmenorrhea amenorrhea.
Herba Epimedii: pungent, sweet, warm.Return liver, kidney channel.Kidney-replenishing, bone and muscle strengthening, wind-damp dispelling.Weak for kidney yang, impotence and seminal emission, muscles and bones wither soft, rheumatic arthralgia, numbness contracture.
Rhizoma Curculiginis: pungent, hot；Return kidney,liver,spleen warp.Kidney-replenishing, bone and muscle strengthening, dispelling cold and dampness.For sexual impotence cold sperm, muscles and bones is withered soft, chills and pain of the waist and kness, yang deficiency cold diarrhea.
The usage of the medicine of the treatment paralysis due to windstroke of the present invention is as follows: per stage medicine potion every day, takes night and morning.First stage medicine and second stage medicine with being decocted in water for oral dose, phase III medicine available water decoction or break into powder be administered orally.Per stage medicine takes one month.
First stage medicine circulation of qi promoting, promoting blood circulation to restore menstrual flow in the medicine of the treatment paralysis due to windstroke of the present invention, after this stage Drug therapy, trick is movable；Second stage medicine blood circulation promoting and enriching, remove wind, can be freely movable after this stage Drug therapy, walk about lowerly；Phase III medicine strongly invigorating primordial QI, is mainly used in recovering health.All medicine reasonable compatibilities in the present invention medicine of each stage, complementary collaborative, dialectical treatment, there is instant effect, good effect, the advantage that has no side effect.
In order to be more fully understood that and implement, the following detailed description of the present invention.
Detailed description of the invention
Embodiment 1
The medicine of the treatment paralysis due to windstroke of the present invention, includes the pharmaceutical composition that 3 stages used respectively altogether, wherein:
First stage pharmaceutical composition includes following components: root of Fructus Schisandrae Chinensis 5 grams, parasitic 5 grams of oil tea, big Caulis Sargentodoxae 5 grams, 5 grams of Rhizoma Curcumae Longae, Caulis Erycibes 5 grams, Herba Lycopodii 5 grams, Ramulus Cinnamomi 5 grams, Radix Achyranthis Bidentatae 5 grams, Radix Codonopsis 5 grams, Olibanum 5 grams, Myrrha 5 grams, Rhizoma Et Radix Notopterygii 5 grams, Radix Angelicae Pubescentis 5 grams, Radix Gentianae Macrophyllae 5 grams, Rhizoma Cyperi 5 grams, the Radix Linderae 5 grams, 5 grams of Radix Rehmanniae Preparata, the Cortex Eucommiae 5 grams, Fructus Aurantii 5 grams；
Second stage pharmaceutical composition includes following components: Rhizoma Arisaematis 5 grams, Caulis Erycibes 5 grams, Herba Lycopodii 5 grams, Radix Achyranthis Bidentatae 5 grams, Rhizoma Cyperi 5 grams, Rhizoma Chuanxiong 5 grams, the Cortex Eucommiae 5 grams, Radix Angelicae Sinensis 5 grams, Rhizoma Coptidis 5 grams, Radix Clematidis 5 grams, Herba Epimedii 5 grams, Os Tigris 5 grams, Rhizoma Curculiginis 5 grams, 5 grams of Radix Rehmanniae Preparata, Cortex Cinnamomi 5 grams, Radix Gentianae Macrophyllae 5 grams, big Caulis Sargentodoxae 5 grams, root of Fructus Schisandrae Chinensis 5 grams, Fructus Chaenomelis 5 grams；
Phase III pharmaceutical composition includes following components: Rhizoma Arisaematis 5 grams, Agkistrodon 5 grams, Radix Aconiti 1 gram, Colla cornus cervi 1 gram, Radix Ginseng 5 grams, Radix Angelicae Sinensis 5 grams, Rhizoma Chuanxiong 5 grams, Cortex Cinnamomi 1 gram, 5 grams of Rhizoma Gastrodiae, Herba Epimedii 5 grams, Semen Cuscutae 5 grams, Ramulus Uncariae Cum Uncis 5 grams, Herba Asari 1 gram, Herba Schizonepetae 5 grams, Rhizoma Acori Graminei 5 grams, 5 grams of the Radix Rehmanniae, 5 grams of Radix Rehmanniae Preparata, Herba Cistanches 5 grams, Cortex Acanthopancis 5 grams, Rhizoma Curculiginis 5 grams.
Embodiment 2
The medicine of the treatment paralysis due to windstroke of the present invention, includes the pharmaceutical composition that 3 stages used respectively altogether, wherein:
First stage pharmaceutical composition includes following components: root of Fructus Schisandrae Chinensis 15 grams, parasitic 15 grams of oil tea, big Caulis Sargentodoxae 15 grams, 12 grams of Rhizoma Curcumae Longae, Caulis Erycibes 10 grams, Herba Lycopodii 15 grams, Ramulus Cinnamomi 12 grams, Radix Achyranthis Bidentatae 15 grams, Radix Codonopsis 15 grams, Olibanum 12 grams, Myrrha 12 grams, Rhizoma Et Radix Notopterygii 12 grams, Radix Angelicae Pubescentis 12 grams, Radix Gentianae Macrophyllae 12 grams, Rhizoma Cyperi 15 grams, the Radix Linderae 15 grams, 15 grams of Radix Rehmanniae Preparata, the Cortex Eucommiae 10 grams, Fructus Aurantii 15 grams；
Second stage pharmaceutical composition includes following components: Rhizoma Arisaematis 10 grams, Caulis Erycibes 10 grams, Herba Lycopodii 15 grams, Radix Achyranthis Bidentatae 15 grams, Rhizoma Cyperi 15 grams, Rhizoma Chuanxiong 15 grams, the Cortex Eucommiae 10 grams, Radix Angelicae Sinensis 15 grams, Rhizoma Coptidis 10 grams, Radix Clematidis 15 grams, Herba Epimedii 15 grams, Os Tigris 15 grams, Rhizoma Curculiginis 10 grams, 15 grams of Radix Rehmanniae Preparata, Cortex Cinnamomi 10 grams, Radix Gentianae Macrophyllae 15 grams, big Caulis Sargentodoxae 15 grams, root of Fructus Schisandrae Chinensis 15 grams, Fructus Chaenomelis 15 grams, Radix Et Rhizoma Rhei 3g；
Phase III pharmaceutical composition includes following components: Rhizoma Arisaematis 10 grams, Agkistrodon 15 grams, Radix Aconiti 10 grams, Colla cornus cervi 10 grams, Radix Ginseng 15 grams, Radix Angelicae Sinensis 15 grams, Rhizoma Chuanxiong 15 grams, Cortex Cinnamomi 5 grams, 15 grams of Rhizoma Gastrodiae, Herba Epimedii 15 grams, Semen Cuscutae 15 grams, Ramulus Uncariae Cum Uncis 15 grams, Herba Asari 10 grams, Herba Schizonepetae 15 grams, Rhizoma Acori Graminei 15 grams, 15 grams of the Radix Rehmanniae, 15 grams of Radix Rehmanniae Preparata, Herba Cistanches 15 grams, Cortex Acanthopancis 15 grams, Rhizoma Curculiginis 10 grams.
Embodiment 3
The medicine of the treatment paralysis due to windstroke of the present invention, includes the pharmaceutical composition that 3 stages used respectively altogether, wherein:
First stage pharmaceutical composition includes following components: root of Fructus Schisandrae Chinensis 8 grams, parasitic 8 grams of oil tea, big Caulis Sargentodoxae 8 grams, 8 grams of Rhizoma Curcumae Longae, Caulis Erycibes 6 grams, Herba Lycopodii 8 grams, Ramulus Cinnamomi 8 grams, Radix Achyranthis Bidentatae 8 grams, Radix Codonopsis 8 grams, Olibanum 8 grams, Myrrha 8 grams, Rhizoma Et Radix Notopterygii 8 grams, Radix Angelicae Pubescentis 8 grams, Radix Gentianae Macrophyllae 8 grams, Rhizoma Cyperi 8 grams, the Radix Linderae 8 grams, 8 grams of Radix Rehmanniae Preparata, the Cortex Eucommiae 6 grams, Fructus Aurantii 8 grams.
Described second stage pharmaceutical composition includes following components: Rhizoma Arisaematis 6 grams, Caulis Erycibes 6 grams, Herba Lycopodii 8 grams, Radix Achyranthis Bidentatae 8 grams, Rhizoma Cyperi 8 grams, Rhizoma Chuanxiong 8 grams, the Cortex Eucommiae 6 grams, Radix Angelicae Sinensis 8 grams, Rhizoma Coptidis 6 grams, Radix Clematidis 8 grams, Herba Epimedii 8 grams, Os Tigris 8 grams, Rhizoma Curculiginis 6 grams, 8 grams of Radix Rehmanniae Preparata, Cortex Cinnamomi 6 grams, Radix Gentianae Macrophyllae 8 grams, big Caulis Sargentodoxae 8 grams, root of Fructus Schisandrae Chinensis 8 grams, Fructus Chaenomelis 8 grams, Radix Et Rhizoma Rhei 4g.
Described phase III pharmaceutical composition includes following components: Rhizoma Arisaematis 6 grams, Agkistrodon 8 grams, Radix Aconiti 3 grams, Colla cornus cervi 3 grams, Radix Ginseng 8 grams, Radix Angelicae Sinensis 8 grams, Rhizoma Chuanxiong 8 grams, Cortex Cinnamomi 2 grams, 8 grams of Rhizoma Gastrodiae, Herba Epimedii 8 grams, Semen Cuscutae 8 grams, Ramulus Uncariae Cum Uncis 8 grams, Herba Asari 3 grams, Herba Schizonepetae 8 grams, Rhizoma Acori Graminei 8 grams, 8 grams of the Radix Rehmanniae, 8 grams of Radix Rehmanniae Preparata, Herba Cistanches 8 grams, Cortex Acanthopancis 8 grams, Rhizoma Curculiginis 6 grams.
Embodiment 4
The medicine of the treatment paralysis due to windstroke of the present invention, includes the pharmaceutical composition that 3 stages used respectively altogether, wherein:
First stage pharmaceutical composition includes following components: root of Fructus Schisandrae Chinensis 12 grams, parasitic 12 grams of oil tea, big Caulis Sargentodoxae 12 grams, 11 grams of Rhizoma Curcumae Longae, Caulis Erycibes 9 grams, Herba Lycopodii 12 grams, Ramulus Cinnamomi 11 grams, Radix Achyranthis Bidentatae 12 grams, Radix Codonopsis 12 grams, Olibanum 11 grams, Myrrha 11 grams, Rhizoma Et Radix Notopterygii 11 grams, Radix Angelicae Pubescentis 11 grams, Radix Gentianae Macrophyllae 11 grams, Rhizoma Cyperi 12 grams, the Radix Linderae 12 grams, 12 grams of Radix Rehmanniae Preparata, the Cortex Eucommiae 9 grams, Fructus Aurantii 12 grams.
Described second stage pharmaceutical composition includes following components: Rhizoma Arisaematis 9 grams, Caulis Erycibes 9 grams, Herba Lycopodii 12 grams, Radix Achyranthis Bidentatae 12 grams, Rhizoma Cyperi 12 grams, Rhizoma Chuanxiong 12 grams, the Cortex Eucommiae 9 grams, Radix Angelicae Sinensis 12 grams, Rhizoma Coptidis 9 grams, Radix Clematidis 12 grams, Herba Epimedii 12 grams, Os Tigris 12 grams, Rhizoma Curculiginis 9 grams, 12 grams of Radix Rehmanniae Preparata, Cortex Cinnamomi 9 grams, Radix Gentianae Macrophyllae 12 grams, big Caulis Sargentodoxae 12 grams, root of Fructus Schisandrae Chinensis 12 grams, Fructus Chaenomelis 12 grams, Radix Et Rhizoma Rhei 5g.
Described phase III pharmaceutical composition includes following components: Rhizoma Arisaematis 9 grams, Agkistrodon 12 grams, Radix Aconiti 8 grams, Colla cornus cervi 8 grams, Radix Ginseng 12 grams, Radix Angelicae Sinensis 12 grams, Rhizoma Chuanxiong 12 grams, Cortex Cinnamomi 4 grams, 12 grams of Rhizoma Gastrodiae, Herba Epimedii 12 grams, Semen Cuscutae 12 grams, Ramulus Uncariae Cum Uncis 12 grams, Herba Asari 8 grams, Herba Schizonepetae 12 grams, Rhizoma Acori Graminei 12 grams, 12 grams of the Radix Rehmanniae, 12 grams of Radix Rehmanniae Preparata, Herba Cistanches 12 grams, Cortex Acanthopancis 12 grams, Rhizoma Curculiginis 9 grams.
Embodiment 5
The medicine of the treatment paralysis due to windstroke of the present invention, includes the pharmaceutical composition that 3 stages used respectively altogether, wherein:
Described first stage pharmaceutical composition includes following components: root of Fructus Schisandrae Chinensis 10 parts, parasitic 10 parts of oil tea, big Caulis Sargentodoxae 10 parts, 10 parts of Rhizoma Curcumae Longae, Caulis Erycibes 8 parts, Herba Lycopodii 10 parts, Ramulus Cinnamomi 10 parts, Radix Achyranthis Bidentatae 10 parts, Radix Codonopsis 10 parts, Olibanum 10 parts, Myrrha 10 parts, Rhizoma Et Radix Notopterygii 10 parts, Radix Angelicae Pubescentis 10 parts, Radix Gentianae Macrophyllae 10 parts, Rhizoma Cyperi 10 parts, the Radix Linderae 10 parts, 10 parts of Radix Rehmanniae Preparata, the Cortex Eucommiae 8 parts, Fructus Aurantii 10 parts.
Described second stage pharmaceutical composition includes following components: Rhizoma Arisaematis 8 parts, Caulis Erycibes 8 parts, Herba Lycopodii 10 parts, Radix Achyranthis Bidentatae 10 parts, Rhizoma Cyperi 10 parts, Rhizoma Chuanxiong 10 parts, the Cortex Eucommiae 8 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Coptidis 8 parts, Radix Clematidis 10 parts, Herba Epimedii 10 parts, Os Tigris 10 parts, Rhizoma Curculiginis 8 parts, 10 parts of Radix Rehmanniae Preparata, Cortex Cinnamomi 8 parts, Radix Gentianae Macrophyllae 10 parts, big Caulis Sargentodoxae 10 parts, root of Fructus Schisandrae Chinensis 10 parts, Fructus Chaenomelis 10 parts.
Described phase III pharmaceutical composition includes following components: Rhizoma Arisaematis 8 parts, Agkistrodon 10 parts, Radix Aconiti 5 parts, Colla cornus cervi 5 parts, Radix Ginseng 10 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Chuanxiong 10 parts, Cortex Cinnamomi 3 parts, 10 parts of Rhizoma Gastrodiae, Herba Epimedii 10 parts, Semen Cuscutae 10 parts, Ramulus Uncariae Cum Uncis 10 parts, Herba Asari 5 parts, Herba Schizonepetae 10 parts, Rhizoma Acori Graminei 10 parts, 10 parts of the Radix Rehmanniae, 10 parts of Radix Rehmanniae Preparata, Herba Cistanches 10 parts, Cortex Acanthopancis 10 parts, Rhizoma Curculiginis 8 parts.
Model case
One left half sided paralysis patient, left hand grip during inspection, after four doses of medicines, finger can be movable, inspection after January, and left hand can be lifted over the top of the head, can anti-cross behind again.
More than one paralytic, is used that the medicine composite for curing of the present invention after each apoplexy, all cure every time and be still living and in good health so far.
The invention is not limited in above-mentioned embodiment, if to the various changes of the present invention or deformation without departing from the spirit and scope of the present invention, if these are changed and deform within the claim and the equivalent technologies scope that belong to the present invention, then the present invention is also intended to comprise these changes and deformation.

Claims (8)

1. the medicine treating paralysis due to windstroke, it is characterised in that: include the pharmaceutical composition that 3 stages used respectively altogether, wherein:
First stage pharmaceutical composition includes the component of following weight portion: root of Fructus Schisandrae Chinensis 5～15 parts, oil tea parasitism 5～15 parts, big Caulis Sargentodoxae 5～15 parts, 5～12 parts of Rhizoma Curcumae Longae, Caulis Erycibes 5～10 parts, Herba Lycopodii 5～15 parts, Ramulus Cinnamomi 5～12 parts, Radix Achyranthis Bidentatae 5～15 parts, Radix Codonopsis 5～15 parts, Olibanum 5～12 parts, Myrrha 5～12 parts, Rhizoma Et Radix Notopterygii 5～12 parts, Radix Angelicae Pubescentis 5～12 parts, Radix Gentianae Macrophyllae 5～12 parts, Rhizoma Cyperi 5～15 parts, the Radix Linderae 5～15 parts, 5～15 parts of Radix Rehmanniae Preparata, the Cortex Eucommiae 5～10 parts, Fructus Aurantii 5～15 parts；
Second stage pharmaceutical composition includes the component of following weight portion: Rhizoma Arisaematis 5～10 parts, Caulis Erycibes 5～10 parts, Herba Lycopodii 5～15 parts, Radix Achyranthis Bidentatae 5～15 parts, Rhizoma Cyperi 5～15 parts, Rhizoma Chuanxiong 5～15 parts, the Cortex Eucommiae 5～10 parts, Radix Angelicae Sinensis 5～15 parts, Rhizoma Coptidis 5～10 parts, Radix Clematidis 5～15 parts, Herba Epimedii 5～15 parts, Os Tigris 5～15 parts, Rhizoma Curculiginis 5～10 parts, 5～15 parts of Radix Rehmanniae Preparata, Cortex Cinnamomi 5～10 parts, Radix Gentianae Macrophyllae 5～15 parts, big Caulis Sargentodoxae 5～15 parts, root of Fructus Schisandrae Chinensis 5～15 parts, Fructus Chaenomelis 5～15 parts；
Phase III pharmaceutical composition includes the component of following weight portion: Rhizoma Arisaematis 5～10 parts, Agkistrodon 5～15 parts, Radix Aconiti 1～10 part, Colla cornus cervi 1～10 part, Radix Ginseng 5～15 parts, Radix Angelicae Sinensis 5～15 parts, Rhizoma Chuanxiong 5～15 parts, Cortex Cinnamomi 1～5 part, 5～15 parts of Rhizoma Gastrodiae, Herba Epimedii 5～15 parts, Semen Cuscutae 5～15 parts, Ramulus Uncariae Cum Uncis 5～15 parts, Herba Asari 1～10 part, Herba Schizonepetae 5～15 parts, Rhizoma Acori Graminei 5～15 parts, 5～15 parts of the Radix Rehmanniae, 5～15 parts of Radix Rehmanniae Preparata, Herba Cistanches 5～15 parts, Cortex Acanthopancis 5～15 parts, Rhizoma Curculiginis 5～10 parts.
2. the medicine for the treatment of paralysis due to windstroke according to claim 1, it is characterized in that: described first stage pharmaceutical composition includes the component of following weight portion: root of Fructus Schisandrae Chinensis 8～12 parts, oil tea parasitism 8～12 parts, big Caulis Sargentodoxae 8～12 parts, 8～11 parts of Rhizoma Curcumae Longae, Caulis Erycibes 6～9 parts, Herba Lycopodii 8～12 parts, Ramulus Cinnamomi 8～11 parts, Radix Achyranthis Bidentatae 8～12 parts, Radix Codonopsis 8～12 parts, Olibanum 8～11 parts, Myrrha 8～11 parts, Rhizoma Et Radix Notopterygii 8～11 parts, Radix Angelicae Pubescentis 8～11 parts, Radix Gentianae Macrophyllae 8～11 parts, Rhizoma Cyperi 8～12 parts, the Radix Linderae 8～12 parts, 8～12 parts of Radix Rehmanniae Preparata, the Cortex Eucommiae 6～9 parts, Fructus Aurantii 8～12 parts.
3. the medicine for the treatment of paralysis due to windstroke according to claim 2, it is characterised in that: described first stage pharmaceutical composition includes the component of following weight portion: root of Fructus Schisandrae Chinensis 10 parts, parasitic 10 parts of oil tea, big Caulis Sargentodoxae 10 parts, 10 parts of Rhizoma Curcumae Longae, Caulis Erycibes 8 parts, Herba Lycopodii 10 parts, Ramulus Cinnamomi 10 parts, Radix Achyranthis Bidentatae 10 parts, Radix Codonopsis 10 parts, Olibanum 10 parts, Myrrha 10 parts, Rhizoma Et Radix Notopterygii 10 parts, Radix Angelicae Pubescentis 10 parts, Radix Gentianae Macrophyllae 10 parts, Rhizoma Cyperi 10 parts, the Radix Linderae 10 parts, 10 parts of Radix Rehmanniae Preparata, the Cortex Eucommiae 8 parts, Fructus Aurantii 10 parts.
4. the medicine for the treatment of paralysis due to windstroke according to claim 1, it is characterized in that: described second stage pharmaceutical composition includes the component of following weight portion: Rhizoma Arisaematis 6～9 parts, Caulis Erycibes 6～9 parts, Herba Lycopodii 8～12 parts, Radix Achyranthis Bidentatae 8～12 parts, Rhizoma Cyperi 8～12 parts, Rhizoma Chuanxiong 8～12 parts, the Cortex Eucommiae 6～9 parts, Radix Angelicae Sinensis 8～12 parts, Rhizoma Coptidis 6～9 parts, Radix Clematidis 8～12 parts, Herba Epimedii 8～12 parts, Os Tigris 8～12 parts, Rhizoma Curculiginis 6～9 parts, 8～12 parts of Radix Rehmanniae Preparata, Cortex Cinnamomi 6～9 parts, Radix Gentianae Macrophyllae 8～12 parts, big Caulis Sargentodoxae 8～12 parts, root of Fructus Schisandrae Chinensis 8～12 parts, Fructus Chaenomelis 8～12 parts.
5. the medicine for the treatment of paralysis due to windstroke according to claim 1, it is characterised in that: described second stage pharmaceutical composition also includes Radix Et Rhizoma Rhei 3～5 parts.
6. the medicine for the treatment of paralysis due to windstroke according to claim 4, it is characterised in that: described second stage pharmaceutical composition includes the component of following weight portion: Rhizoma Arisaematis 8 parts, Caulis Erycibes 8 parts, Herba Lycopodii 10 parts, Radix Achyranthis Bidentatae 10 parts, Rhizoma Cyperi 10 parts, Rhizoma Chuanxiong 10 parts, the Cortex Eucommiae 8 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Coptidis 8 parts, Radix Clematidis 10 parts, Herba Epimedii 10 parts, Os Tigris 10 parts, Rhizoma Curculiginis 8 parts, 10 parts of Radix Rehmanniae Preparata, Cortex Cinnamomi 8 parts, Radix Gentianae Macrophyllae 10 parts, big Caulis Sargentodoxae 10 parts, root of Fructus Schisandrae Chinensis 10 parts, Fructus Chaenomelis 10 parts.
7. the medicine for the treatment of paralysis due to windstroke according to claim 1, it is characterized in that: described phase III pharmaceutical composition includes the component of following weight portion: Rhizoma Arisaematis 6～9 parts, Agkistrodon 8～12 parts, Radix Aconiti 3～8 parts, Colla cornus cervi 3～8 parts, Radix Ginseng 8～12 parts, Radix Angelicae Sinensis 8～12 parts, Rhizoma Chuanxiong 8～12 parts, Cortex Cinnamomi 2～4 parts, 8～12 parts of Rhizoma Gastrodiae, Herba Epimedii 8～12 parts, Semen Cuscutae 8～12 parts, Ramulus Uncariae Cum Uncis 8～12 parts, Herba Asari 3～8 parts, Herba Schizonepetae 8～12 parts, Rhizoma Acori Graminei 8～12 parts, 8～12 parts of the Radix Rehmanniae, 8～12 parts of Radix Rehmanniae Preparata, Herba Cistanches 8～12 parts, Cortex Acanthopancis 8～12 parts, Rhizoma Curculiginis 6～9 parts.
8. the medicine for the treatment of paralysis due to windstroke according to claim 7, it is characterised in that: described phase III pharmaceutical composition includes the component of following weight portion: Rhizoma Arisaematis 8 parts, Agkistrodon 10 parts, Radix Aconiti 5 parts, Colla cornus cervi 5 parts, Radix Ginseng 10 parts, Radix Angelicae Sinensis 10 parts, Rhizoma Chuanxiong 10 parts, Cortex Cinnamomi 3 parts, 10 parts of Rhizoma Gastrodiae, Herba Epimedii 10 parts, Semen Cuscutae 10 parts, Ramulus Uncariae Cum Uncis 10 parts, Herba Asari 5 parts, Herba Schizonepetae 10 parts, Rhizoma Acori Graminei 10 parts, 10 parts of the Radix Rehmanniae, 10 parts of Radix Rehmanniae Preparata, Herba Cistanches 10 parts, Cortex Acanthopancis 10 parts, Rhizoma Curculiginis 8 parts.
CN201610259987.8A 2016-04-22 2016-04-22 Drug for treating stroke paralysis Pending CN105770758A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610259987.8A CN105770758A (en) 2016-04-22 2016-04-22 Drug for treating stroke paralysis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610259987.8A CN105770758A (en) 2016-04-22 2016-04-22 Drug for treating stroke paralysis

Publications (1)

Publication Number Publication Date
CN105770758A true CN105770758A (en) 2016-07-20

Family

ID=56398433

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610259987.8A Pending CN105770758A (en) 2016-04-22 2016-04-22 Drug for treating stroke paralysis

Country Status (1)

Country Link
CN (1) CN105770758A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106729437A (en) * 2017-01-24 2017-05-31 崔建科 It is a kind of to treat Chinese medicine composition of cerebellar atrophy and its preparation method and application
CN108853438A (en) * 2018-09-19 2018-11-23 禹州市中医院 A kind of Chinese medicine composition and preparation method thereof for treating apoplexy sequelae

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1181965A (en) * 1997-08-17 1998-05-20 迟经惠 Injection for curing Xuefen paralysis
CN1259378A (en) * 1999-12-20 2000-07-12 郭言勋 Oral liquid for restoring hemiplegia
CN1327812A (en) * 2000-06-08 2001-12-26 全兵杰 Process for preparing medicine to treat apoplexy hemiplegia
CN1365819A (en) * 2001-01-16 2002-08-28 李君� Medicine for treating apoplexy
CN1422661A (en) * 2002-12-23 2003-06-11 杨丙申 Chinese medicinal proprietary for treating hemiplegic by apoplexia-Fuzhengpiantanwan
CN1861171A (en) * 2006-04-18 2006-11-15 钟龙 Method for preparing traditional Chinese medicine to treat apoplexia hemiplegia and said medicine
CN1876153A (en) * 2005-06-10 2006-12-13 崔赤锋 A preparation method of medicine for treating hemiparalysis caused by apoplexy
CN101194939A (en) * 2007-12-07 2008-06-11 刘晓祥 Chinese medicine prescription for treating early apoplexy and hemiplegia
CN101361923A (en) * 2008-09-11 2009-02-11 周功庚 Traditional Chinese medicine for treating rheumatism
CN102294004A (en) * 2011-08-26 2011-12-28 李丰曹 Medicinal liquor for treating apoplexy and preparation method thereof
CN102366601A (en) * 2011-10-20 2012-03-07 邓华伦 Traditional Chinese medicine preparation for treating apoplexia, facial paralysis and hemiplegia
CN104435551A (en) * 2014-11-26 2015-03-25 张华� Traditional Chinese medicine composition for treating hemiplegia
CN104873946A (en) * 2015-06-15 2015-09-02 谌连生 Traditional Chinese medicine composition for treating paralysis

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1181965A (en) * 1997-08-17 1998-05-20 迟经惠 Injection for curing Xuefen paralysis
CN1259378A (en) * 1999-12-20 2000-07-12 郭言勋 Oral liquid for restoring hemiplegia
CN1327812A (en) * 2000-06-08 2001-12-26 全兵杰 Process for preparing medicine to treat apoplexy hemiplegia
CN1365819A (en) * 2001-01-16 2002-08-28 李君� Medicine for treating apoplexy
CN1422661A (en) * 2002-12-23 2003-06-11 杨丙申 Chinese medicinal proprietary for treating hemiplegic by apoplexia-Fuzhengpiantanwan
CN1876153A (en) * 2005-06-10 2006-12-13 崔赤锋 A preparation method of medicine for treating hemiparalysis caused by apoplexy
CN1861171A (en) * 2006-04-18 2006-11-15 钟龙 Method for preparing traditional Chinese medicine to treat apoplexia hemiplegia and said medicine
CN101194939A (en) * 2007-12-07 2008-06-11 刘晓祥 Chinese medicine prescription for treating early apoplexy and hemiplegia
CN101361923A (en) * 2008-09-11 2009-02-11 周功庚 Traditional Chinese medicine for treating rheumatism
CN102294004A (en) * 2011-08-26 2011-12-28 李丰曹 Medicinal liquor for treating apoplexy and preparation method thereof
CN102366601A (en) * 2011-10-20 2012-03-07 邓华伦 Traditional Chinese medicine preparation for treating apoplexia, facial paralysis and hemiplegia
CN104435551A (en) * 2014-11-26 2015-03-25 张华� Traditional Chinese medicine composition for treating hemiplegia
CN104873946A (en) * 2015-06-15 2015-09-02 谌连生 Traditional Chinese medicine composition for treating paralysis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106729437A (en) * 2017-01-24 2017-05-31 崔建科 It is a kind of to treat Chinese medicine composition of cerebellar atrophy and its preparation method and application
CN108853438A (en) * 2018-09-19 2018-11-23 禹州市中医院 A kind of Chinese medicine composition and preparation method thereof for treating apoplexy sequelae

Similar Documents

Publication Publication Date Title
CN103156972B (en) Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury
CN105343521A (en) Traditional Chinese medicine preparation for treating neck, shoulder, waist and back strain and preparation method thereof
CN105560662A (en) External-use traditional Chinese medicine composition for treating knee osteoarthritis
CN103784622A (en) Traditional Chinese medicine for treating hyperosteogeny arthritis and preparation method thereof
CN105535167A (en) Chinese herb preparation of sport injury spray
CN1317021C (en) Chinese medicinal formulation for stopping pain for removing Bi
CN105770758A (en) Drug for treating stroke paralysis
CN103041301B (en) Traditional Chinese medicine composition for treating icterohepatitis
CN103316296B (en) Traditional Chinese medicine composition for treating hyperostosis
CN102512560B (en) Traditional Chinese medicinal composition for treating arthromyodynia
CN104758720A (en) Traditional Chinese medicine composition for treating impotence
CN103611100A (en) Traditional Chinese medicine for treating toothaches
CN102145099A (en) Traditional Chinese medicine for treating infertility caused by liver stagnation
CN104013941A (en) Traditional Chinese medicinal preparation for treating sprain
CN102406753B (en) Chinese medicinal composition for treating Bi syndrome
CN108096551A (en) A kind of Chinese medicine preparation of cure scapulohumeral periarthritis
CN104721738A (en) Traditional Chinese medicine preparation for treating nipple discharge and preparation method thereof
CN105833152A (en) Traditional Chinese medicine composition for treating endocrine dyscrasia
CN105395810A (en) Traditional Chinese medicine composition for treating marek's disease
CN105688075A (en) Novel oral preparation for treating stomachache and preparation method thereof
CN105688074A (en) Decoction medicine for treating hypogastric pain and preparation method of decoction medicine
CN104758649A (en) Traditional Chinese medicine composition for treating numbness of limbs
CN105169054A (en) Traditional Chinese medicine preparation for treating acute and chronic osteoarthritis and preparation method thereof
CN105031535A (en) Medicinal liquor for treating traumatic injury and preparation method thereof
CN113995796A (en) Medicine for treating spinal injury paraplegia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160720